Compare Alliant Energy Corporation (LNT) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alliant Energy Corporation vs ResMed Inc. — how do they compare? Alliant Energy Corporation trades at $65.85 (market cap $16.99B), while ResMed Inc. trades at $230.05 (market cap $31.89B). The key difference: ResMed Inc. is the larger of the two by market cap, and Alliant Energy Corporation pays the higher dividend (3.27%). Which is the better fit depends on your goals — on Pluang, investors hold Alliant Energy Corporation for 64 Days and ResMed Inc. for 51 Days on average.
| LNT | RMD | |
|---|---|---|
Market Cap | $16.99B | $31.89B |
Volume | 2,488,387 | 618,314 |
Sector | Utilities | Health |
52-Week High | $78.03 | $275.96 |
52-Week Low | $63.21 | $182.82 |
Typical Hold Time | 64 Days | 51 Days |
Enterprise Value | $29.08B | $31.24B |
Dividend Yield | 3.27% | 1.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LNT trades at $65.50, up 0.44% today, with a bullish technical signal and support near $65. The company reported Q2 2026 EPS of $0.65, beating expectations, and maintains a strong net income margin of 18.45%. Recent news highlights a $1.4B partnership and institutional buying, while a $13.4B capital expenditure plan supports long-term growth.
Outlook is positive with a consensus price target of $77, implying 17.6% upside, driven by steady utility demand and data center growth. Risks include rising debt levels and cost pressures. Analysts are bullish with 52% buy ratings, but investors should monitor execution of the capex plan and interest rate impacts.
ResMed (RMD) trades at $226.73, up 0.33% today, with a bullish technical signal from moving averages and a neutral RSI. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending. Revenue grew to $5.15 billion in 2025, with a net income margin of 26.94%, while cash flow from operations reached $1.75 billion. Recent news highlights an upcoming Q1 2027 earnings report and management's focus on 12%-14% EPS growth driven by demand in sleep therapy.
The outlook for RMD is positive, supported by robust fundamentals and analyst consensus, though risks include competitive pressures and ongoing legal investigations. Upside potential exists with a consensus price target of $242.70, representing a 7% increase from current levels, but investors should monitor execution against growth targets and market share dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
